Actively Recruiting

Age: 18Years +
All Genders
NCT06442215

Selection of Surgical Technique in Rectal Cancer

Led by Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Updated on 2024-06-05

333

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Currently, there is no prediction scale available to identify patients with rectal neoplasms as technically complex in the middle and lower thirds; that is, those who are at high risk of affected circumferential margins and low quality of the mesorectum. The application of a predictive model that allows preoperative identification of the group of patients in whom optimal results in mesorectal quality and circumferential margin are less likely to be obtained through laparoscopic or minimally invasive surgery would enable the selection of patients who will require and justify all efforts and healthcare resources to improve surgical outcomes. Therefore, the investigators aim to create a predictive model to identify these patients, allowing the discrimination of which patients will benefit from different techniques, or even which ones would be opportune to initially consider an open approach.

CONDITIONS

Official Title

Selection of Surgical Technique in Rectal Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Scheduled surgery for anterior resection of the rectum meeting oncological criteria with mesorectal excision
  • Age 18 years or older
  • Histology of adenocarcinoma with or without neoadjuvant chemotherapy or chemoradiotherapy
  • Initial stage T1 to T4a, any N, any M
  • Intention for R0 resection
Not Eligible

You will not qualify if you...

  • Colorectal tumor with histology other than adenocarcinoma
  • Presence of synchronous colon tumor
  • Benign pathology or adenoma
  • Tumor classified as Tis
  • Tumor classified as T4b or requiring oncological multivisceral resections
  • History of neoplastic colorectal surgery or local excision or TAMIS
  • Perforated or obstructive rectal neoplasm

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital Universitari Dr. Josep Trueta de Girona

Girona, Spain, 17300

Actively Recruiting

Loading map...

Research Team

N

Nuria Ortega, MD

CONTACT

L

Lidia Cornejo, MSC

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here